What are the clinical and sonographic signs of placental insufficiency and how should it be evaluated and managed?

Signs of Placental Insufficiency

Placental insufficiency manifests through fetal growth restriction (estimated fetal weight <10th percentile), abnormal umbilical artery Doppler studies showing increased resistance or absent/reversed end-diastolic flow, and oligohydramnios, with the most severe cases demonstrating an estimated fetal weight <3rd percentile combined with abnormal Doppler findings. 1, 2

Clinical Signs

Maternal Indicators

• Hypertensive disorders of pregnancy (preeclampsia) are strongly associated with placental insufficiency, particularly in early-onset fetal growth restriction 1, 2
• Fundal height lagging behind gestational age by >3 cm warrants ultrasound evaluation 1
• History of prior delivery with severe growth restriction (e.g., term infant <3rd percentile) indicates markedly increased recurrence risk 3

Fetal Growth Parameters

• Estimated fetal weight <10th percentile is the primary diagnostic threshold for fetal growth restriction 1, 2
• Estimated fetal weight <3rd percentile represents severe placental insufficiency with 3-fold increased stillbirth risk and significantly worse perinatal outcomes 2
• Abdominal circumference <10th percentile is often the earliest biometric sign, as liver glycogen stores deplete first in chronic hypoxemia 1
• Declining growth velocity across serial ultrasounds (crossing percentile lines downward) indicates progressive placental dysfunction 3

Sonographic Signs

Umbilical Artery Doppler Findings (Most Critical)

Umbilical artery Doppler is the only surveillance modality with Level I evidence showing 29% reduction in perinatal mortality and follows a predictable deterioration sequence 3:

• Increased pulsatility index >95th percentile indicates elevated placental resistance; requires weekly Doppler surveillance 1
• Absent end-diastolic flow (AEDV) represents severe compromise with ~70% obliteration of placental tertiary villi; mandates delivery at 33-34 weeks 1, 2, 4
• Reversed end-diastolic flow (REDV) is the most severe finding; requires hospitalization and delivery at 30-32 weeks 1, 2

Cerebral Doppler Abnormalities

• Middle cerebral artery pulsatility index <5th percentile indicates brain-sparing physiology (cerebral vasodilation in response to hypoxemia) 5
• Cerebroplacental ratio (CPR) <5th percentile combines umbilical and middle cerebral artery findings; particularly useful in late-onset (≥32 weeks) growth restriction 5, 6
• Cerebral-placental-uterine ratio (CPUR) shows strongest association with placental insufficiency, detecting 89% of cases with birth weight <3rd percentile at 90% specificity 6

Amniotic Fluid Assessment

• Oligohydramnios (deepest vertical pocket <2 cm or amniotic fluid index <5 cm) reflects chronic fetal hypoxemia and decreased fetal urine output 1
• ACOG considers amniotic fluid an important diagnostic and prognostic parameter, though its value for diagnosis alone is debated 1

Placental Morphology

• Placental infarction ≥10% on ultrasound or MRI strongly predicts severe placental insufficiency 7
• Largest infarct size ≥25 mm differentiates growth restriction from appropriate-for-gestational-age fetuses 7
• Globular placental shape and increased thickness-to-volume ratio ≥0.043 indicate abnormal placental development 7
• Uterine artery Doppler with bilateral notching or elevated pulsatility index suggests impaired placental implantation, though not recommended for routine surveillance 1, 3

Evaluation Algorithm

Initial Assessment When Growth Restriction Suspected

1. Confirm gestational age with first-trimester dating ultrasound to ensure accurate percentile assignment 2
2. Perform detailed anatomic survey (CPT 76811) because 20% of early-onset cases have associated fetal anomalies 2
3. Obtain umbilical artery Doppler immediately at diagnosis 1, 3
4. Assess amniotic fluid volume using deepest vertical pocket or amniotic fluid index 1
5. Evaluate for maternal hypertensive disorders with blood pressure and urinalysis 1

Genetic and Infectious Workup

• Chromosomal microarray analysis is recommended for unexplained isolated growth restriction diagnosed <32 weeks, as chromosomal abnormalities account for ~20% of cases 2, 3
• CMV PCR testing via amniocentesis if diagnostic testing is performed, though routine screening for toxoplasmosis, rubella, or herpes is not recommended without other risk factors 3

Timing-Based Classification

• Early-onset growth restriction (<32 weeks) typically shows more severe placental dysfunction, follows established Doppler deterioration patterns, and has stronger association with maternal hypertensive disorders 2
• Late-onset growth restriction (≥32 weeks) accounts for 70-80% of cases, presents more mildly, and requires cerebroplacental ratio <5th percentile plus abdominal circumference <5th percentile for diagnosis by international consensus 2, 5

Surveillance Protocol After Diagnosis

Doppler Monitoring Frequency

• Normal umbilical artery Doppler: Weekly Doppler assessments 1, 3
• Decreased diastolic flow or severe growth restriction (EFW <3rd percentile): Weekly Doppler 1, 2, 3
• Absent end-diastolic flow: Doppler 2-3 times weekly 1, 2, 3
• Reversed end-diastolic flow: Doppler 3 times weekly with daily consultant involvement 1, 3

Cardiotocography (NST/Biophysical Profile)

• Weekly cardiotocography after viability for growth restriction without absent/reversed flow 1, 3
• Twice weekly or more when absent end-diastolic flow present 1, 2, 3
• Daily cardiotocography 1-2 times daily for reversed end-diastolic flow 1, 3
• Critical caveat: Normal fetal heart rate testing does NOT exclude progression of growth restriction and should never be the sole surveillance method 3

Growth Assessment

• Fetal biometry every 2 weeks minimum; more frequent measurements (weekly) are unreliable due to inherent ultrasound error 1, 3
• Every 3-4 weeks is optimal for detecting true growth velocity changes 2, 3

Management Based on Severity

Delivery Timing by Doppler Findings

• Normal Doppler, EFW 3rd-10th percentile: Deliver at 38-39 weeks 2, 3
• Decreased diastolic flow or EFW <3rd percentile: Deliver at 37 weeks 2, 3
• Absent end-diastolic flow: Deliver at 33-34 weeks 1, 2, 3, 4
• Reversed end-diastolic flow: Deliver at 30-32 weeks 1, 2, 3

Preterm Management (<34 Weeks with AEDV/REDV)

• Hospitalize immediately (mandatory for reversed flow) 1, 3, 4
• Betamethasone 12 mg IM, repeat after 24 hours for fetal lung maturation 1, 2, 3
• Magnesium sulfate 4-6 g IV loading dose for neuroprotection if delivery anticipated <32 weeks 1, 2, 3
• Observe 48-72 hours after corticosteroid administration before delivery unless acute deterioration 3

Mode of Delivery

• Cesarean delivery strongly recommended for absent or reversed end-diastolic flow due to severe placental insufficiency and high risk of intrapartum compromise 1, 2, 4
• Studies show 75-95% of growth-restricted pregnancies with absent/reversed flow require cesarean for intrapartum heart rate abnormalities 3

Critical Pitfalls to Avoid

• Never rely solely on cardiotocography or biophysical profile, as early/compensated growth restriction maintains normal heart rate patterns while Doppler already shows vascular compromise 3
• Do not use umbilical artery Doppler for screening in low-risk pregnancies; it is only validated after growth restriction is diagnosed 3
• Avoid delaying delivery beyond recommended gestational ages based on Doppler findings, as perinatal mortality exceeds 20% with absent flow managed expectantly 4
• Never attempt labor induction with absent/reversed flow, as these fetuses cannot tolerate contraction stress 4
• Do not confuse simple small-for-gestational-age (constitutionally small with normal Doppler and outcomes) with true growth restriction showing placental dysfunction 2, 8
• Obtain cord arterial and venous pH at all growth-restricted deliveries to document degree of compromise 1
• Send placenta for histopathologic examination in all cases to understand underlying causes and guide future pregnancy management 1